Cite
HARVARD Citation
Zhou, D. et al. (2022). Simvastatin Inhibits Endometrial Cancer Malignant Behaviors by Suppressing RAS/Mitogen-Activated Protein Kinase (MAPK) Pathway-Mediated Reactive Oxygen Species (ROS) and Ferroptosis. Evidence-based complementary and alternative medicine. p. . [Online].